<DOC>
	<DOCNO>NCT01297972</DOCNO>
	<brief_summary>Mesenchymal stem cell test many autoimmune disorder encouraging result may alternative treatment immune-mediated severe acquire aplastic anemia .</brief_summary>
	<brief_title>Mesenchymal Stem Cells Treatment Relapsed/Refractory Severe Acquired Aplastic Anemia</brief_title>
	<detailed_description>Acquired aplastic anemia bone marrow failure syndrome characterize empty bone marrow low blood count . Most case immune-mediated . Allogeneic bone marrow transplant preferable treatment modality patient young 40 year match sibling donor . Patients eligible transplant treat intensive immunosuppressive therapy often base anti-thymocyte globulin cyclosporine . However , one third patient treat immunosuppression refractory one third response eventually relapse . Refractory relapse case may result insufficient immunosuppression case may benefit additional immunosuppression . Mesenchymal stem cell infusion may potential treatment option , consider property modulate immune system . Refractory relapse patient aplastic anemia treat conventional immunosuppressive regimen ( anti-thymocyte globulin plus cyclosporine ) combine intravenous infusion allogeneic unrelated bone marrow mesenchymal stem cell .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<criteria>Diagnosis Acquired Aplastic Anemia Relapse/refractory least 1 immunosuppressive first line treatment Not eligible allogeneic bone marrow transplantation Previous current malignancy Active latent infectious disease Positive serologic test HIV , HCV , HBV , HTLV1 2 , Syphilis Chagas disease Previous drug reaction antithymocyte globulin , cyclosporin corticosteroid Severe organic impairment ( renal , hepatic , cardiac , pulmonary ) Uncontrolled hypertension diabetes Pregnancy Previous history allergic reaction penicillin streptomycin Severe psychiatric disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Aplastic Anemia</keyword>
	<keyword>Mesenchymal Stem Cells</keyword>
</DOC>